5940-00-1 Usage
Uses
Used in Oncology:
Darutigenol is used as an antitumor agent for its ability to inhibit the growth of various cancer cell lines, including breast, lung, and colon cancer. It functions by inducing apoptosis in cancer cells, offering a potential therapeutic approach for cancer treatment.
Used in Anti-Inflammatory Applications:
Due to its anti-inflammatory properties, Darutigenol is used in the management of inflammation, which can be associated with various diseases and conditions, including cancer.
Used in Drug Development:
As a potential candidate for the development of new cancer treatment options, Darutigenol is used in pharmaceutical research and development to explore its efficacy and safety in clinical trials, with the aim of advancing cancer therapeutics.
Check Digit Verification of cas no
The CAS Registry Mumber 5940-00-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,4 and 0 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5940-00:
(6*5)+(5*9)+(4*4)+(3*0)+(2*0)+(1*0)=91
91 % 10 = 1
So 5940-00-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H14N2O4/c1-19(2)12-8-6-11(7-9-12)10-14-17(21)13-4-3-5-15(20(23)24)16(13)18(14)22/h3-10H,1-2H3/b14-10+
5940-00-1Relevant academic research and scientific papers
Cytotoxic germacrane-type sesquiterpenes, pimarane-type diterpenes, and a naphthalene derivative from Wollastonia biflora
Chen, Wenliang,Tang, Weidong,Zhang, Rujun,Lou, Liguang,Zhao, Weimin
, p. 567 - 570 (2008/02/13)
Phytochemical investigation of the whole plants of Wollastonia biflora led to the isolation and identification of three new germacrane-type sesquiterpenes (1-3), two new pimarane-type diterpenes (4, 5), and a new naphthalene glycoside (6), along with 11 known compounds. Their structures were characterized on the basis of spectroscopic analyses and chemical methods. Compounds 1, 2, and 3 showed significant cytotoxic activity against me growth of hepatocellular carcinoma BEL-7402 cells in vitro.
